PF-04494700

· Pfizer

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for PF-04494700, covering 2009-08-20 to 2018-11-30. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease [Phase 2]

See pricing